NATCOPHARM Financial Statements

Natco Pharma Profit & Loss Statement

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 7.16 (12) 8.15 93.80
Op profit growth 4.05 (37) 35.90 157
EBIT growth 0.46 (35) 40.40 186
Net profit growth (4.30) (34) 43.30 209
Profitability ratios (%)        
OPM 29.50 30.40 42.50 33.80
EBIT margin 28.90 30.80 41.30 31.80
Net profit margin 21.50 24.10 31.90 24.10
RoCE 13.90 16 35 38.70
RoNW 2.79 3.37 7.37 8.25
RoA 2.58 3.12 6.75 7.31
Per share ratios ()        
EPS 24.20 25.20 37.70 27.80
Dividend per share 5.25 6.75 8.25 6.75
Cash EPS 17.80 19.80 34.10 24.80
Book value per share 226 207 167 94.60
Valuation ratios        
P/E 34 20.10 20 30.50
P/CEPS 46.40 25.50 22.10 34.20
P/B 3.65 2.44 4.53 8.95
EV/EBIDTA 21.20 13.70 14.40 21.40
Payout (%)        
Dividend payout 25.80 27.60 21.90 24.20
Tax payout (24) (19) (22) (22)
Liquidity ratios        
Debtor days 85.70 113 92.90 66.60
Inventory days 121 95 65.80 63.80
Creditor days (60) (86) (96) (89)
Leverage ratios        
Interest coverage (45) (27) (59) (35)
Net debt / equity -- 0.07 -- 0.11
Net debt / op. profit -- 0.43 -- 0.27
Cost breakup ()        
Material costs (25) (20) (19) (30)
Employee costs (20) (20) (15) (12)
Other costs (25) (30) (24) (24)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 2,052 1,915 2,185 2,020
yoy growth (%) 7.16 (12) 8.15 93.80
Raw materials (511) (382) (411) (599)
As % of sales 24.90 19.90 18.80 29.70
Employee costs (415) (375) (326) (243)
As % of sales 20.20 19.60 14.90 12
Other costs (520) (576) (520) (495)
As % of sales 25.30 30.10 23.80 24.50
Operating profit 606 583 928 683
OPM 29.50 30.40 42.50 33.80
Depreciation (117) (100) (66) (54)
Interest expense (13) (22) (15) (19)
Other income 104 107 40.40 13.90
Profit before tax 580 569 887 624
Taxes (137) (111) (192) (140)
Tax rate (24) (19) (22) (22)
Minorities and other (1.50) 2.70 1 1.10
Adj. profit 441 461 696 486
Exceptional items -- -- -- --
Net profit 441 461 696 486
yoy growth (%) (4.30) (34) 43.30 209
NPM 21.50 24.10 31.90 24.10
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax 580 569 887 624
Depreciation (117) (100) (66) (54)
Tax paid (137) (111) (192) (140)
Working capital 1,787 1,769 1,459 450
Other operating items -- -- -- --
Operating cashflow 2,112 2,128 2,088 881
Capital expenditure 2,328 1,708 681 339
Free cash flow 4,440 3,836 2,768 1,219
Equity raised 4,091 3,851 2,999 1,941
Investments 241 49.80 74.20 30.30
Debt financing/disposal 193 77.60 (54) (3.50)
Dividends paid 114 127 152 118
Other items -- -- -- --
Net in cash 9,078 7,942 5,940 3,304
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 36.50 36.40 36.50 36.90
Preference capital -- -- -- --
Reserves 4,085 3,737 3,453 3,035
Net worth 4,122 3,774 3,489 3,072
Minority interest
Debt 268 316 386 173
Deferred tax liabilities (net) 41.30 25.90 40.30 14.60
Total liabilities 4,432 4,127 3,918 3,264
Fixed assets 2,247 2,102 1,865 1,499
Intangible assets
Investments 304 112 169 76.50
Deferred tax asset (net) -- -- 28.70 0.70
Net working capital 1,599 1,846 1,576 1,504
Inventories 798 558 529 438
Inventory Days 142 106 -- 73.20
Sundry debtors 413 551 506 638
Debtor days 73.40 105 -- 107
Other current assets 747 1,198 955 880
Sundry creditors (181) (296) (265) (336)
Creditor days 32.20 56.40 -- 56.10
Other current liabilities (178) (166) (149) (116)
Cash 284 66 280 184
Total assets 4,432 4,127 3,918 3,264
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2022 Dec-2021 Sep-2021 Jun-2021 Mar-2021
Gross Sales 597 561 377 410 331
Excise Duty -- -- -- -- --
Net Sales 597 561 377 410 331
Other Operating Income -- -- -- -- --
Other Income 13.80 30.20 38 17 28.40
Total Income 611 591 415 427 360
Total Expenditure ** 615 459 307 301 255
PBIDT (4.80) 132 109 127 105
Interest 6.70 5 4 2 3.50
PBDT (12) 127 105 125 101
Depreciation 38.10 36 34.70 33.80 30.40
Minority Interest Before NP -- -- -- -- --
Tax (0.60) 16.70 16.10 15.60 25.80
Deferred Tax 1.50 (6.10) (11) 0.40 (8.10)
Reported Profit After Tax (51) 80.40 65.10 75 53
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest (51) 80.40 65.10 75 53
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item (51) 80.40 65.10 75 53
EPS (Unit Curr.) (2.80) 4.41 3.57 4.11 2.91
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- 100 25 100 --
Equity 36.50 36.50 36.50 36.50 36.50
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) (0.80) 23.60 28.80 30.90 31.60
PBDTM(%) (1.90) 22.70 27.70 30.40 30.50
PATM(%) (8.50) 14.30 17.30 18.30 16
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity